IRIS
DI BENEDETTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.247
AS - Asia 1.885
EU - Europa 1.725
SA - Sud America 182
AF - Africa 26
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.200
SG - Singapore 876
IE - Irlanda 534
CN - Cina 445
SE - Svezia 223
HK - Hong Kong 204
TR - Turchia 198
IT - Italia 192
RU - Federazione Russa 176
BR - Brasile 166
DE - Germania 165
UA - Ucraina 129
GB - Regno Unito 111
FI - Finlandia 60
FR - Francia 54
VN - Vietnam 52
IN - India 40
CA - Canada 30
BE - Belgio 28
ID - Indonesia 11
MX - Messico 10
PL - Polonia 10
JP - Giappone 9
ZA - Sudafrica 9
BD - Bangladesh 8
CZ - Repubblica Ceca 8
EC - Ecuador 7
ES - Italia 7
AR - Argentina 6
LT - Lituania 5
NL - Olanda 5
AU - Australia 4
DZ - Algeria 4
IQ - Iraq 4
KR - Corea 4
LB - Libano 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CH - Svizzera 3
EG - Egitto 3
EU - Europa 3
JM - Giamaica 3
JO - Giordania 3
MK - Macedonia 3
PK - Pakistan 3
TN - Tunisia 3
IL - Israele 2
KW - Kuwait 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
UY - Uruguay 1
VE - Venezuela 1
Totale 7.075
Salva come PNG Salva come JPEG
Città #
Chandler 603
Dublin 534
Jacksonville 530
Singapore 447
Dallas 214
Hong Kong 202
Santa Clara 173
Ashburn 158
Boardman 148
Izmir 137
New York 106
Ann Arbor 95
Beijing 92
L'aquila 82
Nanjing 80
Lawrence 75
Princeton 75
Wilmington 63
The Dalles 50
Los Angeles 49
San Mateo 44
Dearborn 42
Moscow 42
Woodbridge 35
Nanchang 31
Dong Ket 26
L’Aquila 26
Milan 25
Brussels 24
Munich 24
Columbus 23
Helsinki 22
Hefei 21
Shanghai 19
São Paulo 19
Verona 19
Kunming 16
Mountain View 16
Seattle 16
Shenyang 16
Council Bluffs 15
Jiaxing 14
Des Moines 11
Hebei 11
Houston 11
Zhengzhou 11
Montreal 10
Pune 10
Tianjin 10
Changsha 9
Chennai 9
Chicago 9
Ho Chi Minh City 9
Ningbo 9
Tokyo 9
Warsaw 9
Grafing 8
Jinan 8
Johannesburg 8
Norwalk 8
San Francisco 8
Stockholm 8
Frankfurt am Main 7
Guangzhou 7
Jakarta 7
Phoenix 7
Brno 6
Hanoi 6
London 6
Rio de Janeiro 6
Rome 6
Toronto 6
Atlanta 5
Bremen 5
Denver 5
Edinburgh 5
Hangzhou 5
Lanzhou 5
Manchester 5
Orem 5
Pescara 5
Poplar 5
Ankara 4
Brasília 4
Falkenstein 4
Fremont 4
Leuven 4
Mexico City 4
Ottawa 4
Redwood City 4
Tashkent 4
Washington 4
Amman 3
Amsterdam 3
Belo Horizonte 3
Brooklyn 3
Changchun 3
Guayaquil 3
Mosul 3
Mumbai 3
Totale 4.811
Salva come PNG Salva come JPEG
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 146
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 138
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 137
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 130
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 130
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 130
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 129
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 128
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 128
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 127
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 122
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 122
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 119
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 119
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 115
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 113
Cardiovascular disease in primary sjögren’s syndrome 113
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 112
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 110
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 108
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 107
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 107
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 105
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 103
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 103
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 102
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 102
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 101
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 101
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 100
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 98
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 97
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 97
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 96
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 96
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 95
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 93
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 93
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 92
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 91
Interstitial lung disease in systemic sclerosis: current and future treatment. 91
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 90
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 90
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 90
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 89
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 89
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 88
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 88
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 87
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 86
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 86
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 86
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 86
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 86
Cellular players in angiogenesis during the course of systemic sclerosis. 84
FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis 83
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 81
The Vessels Contribute to Fibrosis in Systemic Sclerosis 80
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 79
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 79
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 79
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 78
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 76
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 76
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 74
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 74
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 71
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 69
Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2 69
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives 69
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 67
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 64
Potential of stem cells in the treatment of rheumatic disease 59
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 56
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor 53
Phenotypical and functional characteristics of in vitro-expanded adipose-derived mesenchymal stromal cells from patients with systematic sclerosis 49
Totale 7.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021417 0 0 0 0 0 38 90 14 85 26 114 50
2021/2022457 25 16 97 38 11 10 4 24 33 38 37 124
2022/20231.580 113 115 29 199 108 166 2 95 675 12 46 20
2023/2024377 60 21 21 29 35 132 9 16 1 15 4 34
2024/20251.492 38 28 146 56 230 121 165 92 330 69 119 98
2025/20261.250 198 260 143 313 282 54 0 0 0 0 0 0
Totale 7.256